The co-occurrence of Substance Use Disorder (SUD) for people living with HIV (PLWH) may impact HIV transmission, morbidity, and mortality but is not a contraindication for HIV treatments such as antiretroviral therapy (ART). Guidelines from the U.S. Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) direct clinicians to screen for potential mental health disorders and provide ART to PLWH and SUD, but education is required for clinicians to understand and meet the treatment challenges for these individuals and choose between the various ART treatment options to meet their unique needs.
This CMEO BriefCase entitled, People Living with HIV (PLWH) and Substance Abuse Disorder (SUD): Addressing Barriers to Viral Suppression, will discuss a specific case of an individual who must simultaneously face the challenges of living with HIV as well as having a SUD. Expert faculty will address mental health screening and different ART treatment options for HIV given the difficulties and unique barriers faced by patients with a comorbid condition of SUD.
Implement strategies to overcome barriers to viral suppression in PLWH and co-occurring SUD.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Primary care practitioners, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in HIV.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Fingerhood reports no financial relationships to disclose.
Dr. Dawson-Rose reports no financial relationships to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).